PMGC HOLDINGS INC. Cash and Restricted Cash
PMGC HOLDINGS INC. (ELAB) had Cash and Restricted Cash of $18.14 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-14
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $18.14M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $14.35M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.40M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $7.70M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $18.14M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $14.35M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $5.40M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $7.70M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $5.68M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $5.36M 10-Q · filed 2026-05-15 | |
| 2024-12-31 | $3.98M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $6.43M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $100.03K 10-Q · filed 2025-08-13 | |
| 2024-03-31 | $943.80K 10-Q · filed 2025-05-14 | |
| 2023-12-31 | $3.33M 10-K · filed 2026-03-30 | |
| 2023-09-30 | $476.86K 10-Q · filed 2024-11-14 | $476.86M 10-Q · filed 2023-12-11 |
| 2023-06-30 | $601.26K 10-Q · filed 2024-08-14 | |
| 2023-03-31 | $1.05M 10-Q · filed 2024-05-15 | |
| 2022-12-31 | $1.15M 10-K · filed 2025-03-28 | $1.15B 10-Q · filed 2023-12-11 |
| 2022-09-30 | $1.57B 10-Q · filed 2023-12-11 | |
| 2021-12-31 | $411.86K 10-K · filed 2024-03-29 | $411.86M 10-Q · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |